GlassScriptPhysician profile
Rodrigo Lago
NPI 1821269697
$26,984.90
in general payments reported to CMS, 2019-2025
17 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,061 · 2020: $5,663 · 2021: $187 · 2022: $7,230 · 2023: $5,566 · 2024: $1,868 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,726 · Food and Beverage: $2,306 · Travel and Lodging: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,726.12 |
| Food and Beverage | $2,306.16 |
| Travel and Lodging | $812.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,468.37 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,753.18 | 2023-2024 | Jardiance |
| Abbott Laboratories | $2,433.97 | 2019-2025 | Mitraclip, Navitor, Ensite |
| Edwards Lifesciences Corporation | $411.85 | 2022-2025 | Pascal, Evoque |
| Medtronic, INC. | $295.52 | 2023-2025 | Apollotm, Corevalve Evolut R |
| Impulse Dynamics (USA) INC. | $161.81 | 2025 | Optimizer |
| Heartflow, INC. | $109.15 | 2023-2025 | Ffrct |
| Atricure, INC. | $91.64 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System |
| Kestra Medical Technology Services, INC. | $83.51 | 2023 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $31.74 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $30.83 | 2024 | Arcalyst |
| Philips North America LLC | $21.59 | 2024 | (P77) Azurion 7 M20 |
| Teleflex LLC | $21.45 | 2023 | Manta |
| E.R. Squibb & Sons, L.L.C. | $18.63 | 2024 | Camzyos |
| Abiomed | $18.20 | 2024 | Impella |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.87 | 2024 | Andexxa |
| Pfizer INC. | $16.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodrigo Lago listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.